Product and service innovation is a complex environment to navigate, with processes becoming more advanced and the market more disruptive. The Enterprise Hub can support you to stay relevant and competitive by integrating interdisciplinary research and cutting-edge strategies into your existing business operations. 

We can test new ways to transform your existing supply chain, processes or techniques through automation and nanotechnology, leading to increased efficiency or optimised product life cycles. Projects can be tailored to your requirements, and include identifying new product opportunities, adding value to existing products, research and validation.

We have an extensive network of industry partners, and can leverage their expertise when collaborating with you, giving you a competitive edge. We’ll work with you in our specialist facilities to trial, explore and integrate new technology, creating opportunities for your business to innovate and thrive.  

Contact us

A researcher examining materials

Evolve current practice to create or improve products

battery-power-energy

Address unique challenges

Access leading edge design and advanced technologies

global-currency-money-business

Build market resilience

Increase business capability and growth in local and global markets

factory-clean-manufacturing

Create a relative advantage

Enhance sustainability, productivity and profitability

cloud-upload

Innovation opportunities

Take advantage of advanced manufacturing and Industry 4.0 technologies

Case studies

Adaptable, affordable vaccines for multiple conditions

Despite safe and effective vaccines being available for a wide range of infectious diseases, prevention and treatment of more complex conditions, including allergy and cancer, remain elusive. Furthermore, vaccines are complex to manufacture, making them difficult to produce to a scale, quality and cost that supports widespread global access. An ongoing collaboration between South Australian biotech company Sementis Ltd and UniSA’s Experimental Therapeutics Laboratory has developed a vaccine delivery platform that can potentially produce easy-to-manufacture vaccines for multiple acute and chronic disease conditions.

Read more

“The collaboration with UniSA over the past 11 years has resulted in the development of what is Australia’s most advanced viral-vector vaccine technology platform technology, and we look forward to continuing the collaboration to support the work of Sementis to scale this vaccine technology ready for clinical trials.”

Leanne Hobbs, CEO, Sementis

Better cancer detection for more precise treatment

In partnership with medical device company, Ferronova, researchers from UniSA’s Future Industries Institute (FII), Dr Aidan Cousins and Professor Benjamin Thierry, have developed a biodiagnostic system to refine cancer detection. The system consists of a magnetic probe and injectable magnetic nanoscale tracers, able to detect the spread of cancer less invasively, more quickly, and more accurately than existing methods. It delivers an accurate and affordable system for the staging of deep or complex cancers, such as head and neck, gastrointestinal and oesophageal cancers.

Read more

“Translating university IP into human trials is a significant undertaking, and the Ferronova nanoparticle technology is one of the first new magnetic nanoparticle technologies to be translated to the clinic in over 20 years... The collaboration has been positive for both UniSA and Ferronova.”

Stewart Bartlett, CEO, Ferronova

Related services

Contact the Enterprise Hub

Get in touch with us to find out how we can support your business needs.

Make an enquiry online to discuss your idea.